Dino Amadori

Osteoncology and Rare Tumors Center, IRCCS

Affiliated withIRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Research Area

Cancer Research

Biography

Dino Amadori has not added Biography.
If you are Dino Amadori and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 6	2017
Publication title Cited by 16	2018
Publication title Cited by 9	2018

Other Publications

Article	Year
Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17145818	2006
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial. European urology\| PubMed ID: 17207911	2007
Personal use of hair dyes and hematolymphopoietic malignancies. Archives of environmental & occupational health\| PubMed ID: 17290845	2005
[Telomerase activity: a molecular marker for early diagnosis of bladder tumor]. Recenti progressi in medicina\| PubMed ID: 17439065	2007
Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics. Journal of cellular physiology\| PubMed ID: 17458894	2007
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup anal... Breast cancer research and treatment\| PubMed ID: 17530429	2008
Urine telomerase activity for the detection of bladder cancer in females. The Journal of urology\| PubMed ID: 17574060	2007
Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine. Cellular oncology : the official journal of the International Society for Cellular Oncology\| PubMed ID: 17641412	2007
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines. Journal of translational medicine\| PubMed ID: 17971198	2007
Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations. Breast cancer research and treatment\| PubMed ID: 18092194	2008
Disease family history and modification of breast cancer risk in common BRCA2 variants. Oncology reports\| PubMed ID: 18288416	2008
Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study. The oncologist\| PubMed ID: 18378544	2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells. Nitric oxide : biology and chemistry\| PubMed ID: 18472019	2008
Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells. Journal of cellular physiology\| PubMed ID: 18615564	2008
Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control study. American journal of industrial medicine\| PubMed ID: 18651579	2008
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line. Journal of translational medicine\| PubMed ID: 18691406	2008
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting. Clinical drug investigation\| PubMed ID: 18783303	2008
Activity of lipoplatin in tumor and in normal cells in vitro. Anti-cancer drugs\| PubMed ID: 18827563	2008
Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer. Journal of translational medicine\| PubMed ID: 18976450	2008
Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer. Cellular oncology : the official journal of the International Society for Cellular Oncology\| PubMed ID: 19096146	2009
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines. Journal of cellular physiology\| PubMed ID: 19288493	2009
The current role of telomerase in the diagnosis of bladder cancer. Indian journal of urology : IJU : journal of the Urological Society of India\| PubMed ID: 19468427	2009
Multidisciplinary approach to the treatment of bone metastases: Osteo-Oncology Center, a new organizational model. Tumori\| PubMed ID: 19688966	2009
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer. Cancer chemotherapy and pharmacology\| PubMed ID: 19693503	2010
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines. Anti-cancer drugs\| PubMed ID: 19752719	2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression. The Prostate\| PubMed ID: 19790230	2010
Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models. Journal of cellular and molecular medicine\| PubMed ID: 20015197	2011
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients. The International journal of biological markers\| PubMed ID: 20082275	2009
Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer\| PubMed ID: 20108337	2010
[18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20177016	2010
Modulation of mismatch repair and genomic stability by miR-155. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20351277	2010
Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells. Current cancer drug targets\| PubMed ID: 20384581	2010
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer. Oncology\| PubMed ID: 20530973	2010
Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 20929882	2010
Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stim... American journal of hematology\| PubMed ID: 20954262	2011
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21078976	2010
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3... Breast cancer research and treatment\| PubMed ID: 21132360	2011
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA\| PubMed ID: 21205967	2011
Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: role of Golgi apparatus. Journal of cellular physiology\| PubMed ID: 21302303	2011
Time-dependent pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer. Journal of clinical pharmacology\| PubMed ID: 21383342	2012
Managing chronic pain: results from an open-label study using MC5-A Calmare® device. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 21394458	2012
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21464403	2011
Bone metastases detection by circulating biomarkers: OPG and RANK-L. International journal of oncology\| PubMed ID: 21491082	2011
Reproducibility of results on chronic pain with MC5-A Calmare® device from independent studies. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 21547446	2011
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer. Hepato-gastroenterology\| PubMed ID: 21661438	2011
Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. Gastrointestinal cancer research : GCR\| PubMed ID: 21673874	2011
Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy. Journal of translational medicine\| PubMed ID: 21689426	2011
The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot study. Oncology\| PubMed ID: 21734413	2011
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. Clinical breast cancer\| PubMed ID: 21764390	2011
Expectations of survivors, caregivers and healthcare providers for testicular cancer survivorship and quality of life. Tumori\| PubMed ID: 21789018	2011
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature medicine\| PubMed ID: 21822286	2011
Tumorlets in familial history of bronchopulmonary carcinoid. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 21849858	2011
Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches. Journal of clinical pathology\| PubMed ID: 22039286	2012
Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium. The oncologist\| PubMed ID: 22042788	2011
Clinical implications of microRNAs in lung cancer. Seminars in oncology\| PubMed ID: 22082763	2011
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study. Radiation oncology (London, England)\| PubMed ID: 22099067	2011
Dose intensification in hormone receptor-negative and/or human epidermal growth factor receptor 2-negative high-risk primary breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 22203774	2012
Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity. Journal of cellular physiology\| PubMed ID: 22212895	2012
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review. Tumori\| PubMed ID: 22322832	2011
Prospective observational Italian study on palliative sedation in two hospice settings: differences in casemixes and clinical care. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 22361826	2012
Prospective comparison of prognostic scores in palliative care cancer populations. The oncologist\| PubMed ID: 22379068	2012
Palliative sedation in end-of-life care and survival: a systematic review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 22412129	2012
Pancreatic resection for metastases from renal cancer: long term outcome after surgery and immunotherapy approach - single center experience. Hepato-gastroenterology\| PubMed ID: 22469709	2012
Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients. International journal of oncology\| PubMed ID: 22504767	2012
Ipilimumab in advanced melanoma: reports of long-lasting responses. Melanoma research\| PubMed ID: 22516968	2012
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study. Journal of translational medicine\| PubMed ID: 22569004	2012
Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma. Hematology reports\| PubMed ID: 22586509	2011
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy. Journal of Cancer\| PubMed ID: 22670158	2012
Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential. Expert review of anticancer therapy\| PubMed ID: 22716491	2012
Perspectives on mTOR inhibitors for castration-refractory prostate cancer. Current cancer drug targets\| PubMed ID: 22831278	2012
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer. Breast (Edinburgh, Scotland)\| PubMed ID: 23022045	2012
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nature cell biology\| PubMed ID: 23086238	2012
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data. Urologic oncology\| PubMed ID: 23141783	2013
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid. Cancer cell international\| PubMed ID: 23173568	2012
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact. Oncology\| PubMed ID: 23257904	2013
Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer. Clinical colorectal cancer\| PubMed ID: 23332421	2013
Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors. Heart (British Cardiac Society)\| PubMed ID: 23349345	2013
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer. Tumori\| PubMed ID: 23389354	2012
miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nature cell biology\| PubMed ID: 23396050	2013
Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines. International journal of oncology\| PubMed ID: 23403907	2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer letters\| PubMed ID: 23419522	2013
Multiple marker detection in peripheral blood for NSCLC diagnosis. PloS one\| PubMed ID: 23468981	2013
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase ... The oncologist\| PubMed ID: 23475636	2013
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. BioMed research international\| PubMed ID: 23509700	2013
Hemangioblastoma of the gastrointestinal tract: a first case. International journal of surgical pathology\| PubMed ID: 23516170	2013
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue. Journal of clinical pathology\| PubMed ID: 23533259	2013
A randomized phase II non-comparative study of pemetrexed‑carboplatin and gemcitabine‑vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients. International journal of oncology\| PubMed ID: 23546172	2013
Metastatic bone disease in the era of bone-targeted therapy: clinical impact. Tumori\| PubMed ID: 23548992	2013
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer. Breast cancer research and treatment\| PubMed ID: 23649189	2013
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models. PloS one\| PubMed ID: 23667504	2013
Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. International journal of molecular sciences\| PubMed ID: 23681013	2013
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-in... The Lancet. Oncology\| PubMed ID: 23684411	2013
Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? Journal of cellular physiology\| PubMed ID: 23702823	2013
RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. International journal of molecular sciences\| PubMed ID: 23702841	2013
Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): an observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare ... Annals of surgical oncology\| PubMed ID: 23709100	2013
Biofunctional characteristics of in situ and invasive breast carcinoma. Cellular oncology (Dordrecht)\| PubMed ID: 23807750	2013
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 23945199	2013
What can we learn from the ZOOM trial?--Authors' reply. The Lancet. Oncology\| PubMed ID: 23993381	2013
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled pha... Breast cancer research and treatment\| PubMed ID: 24129974	2013
Bone and cancer: the osteoncology. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases\| PubMed ID: 24133529	2013
Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis. Cancer cell\| PubMed ID: 24135284	2013
A new emergency in oncology: Bone metastases in breast cancer patients (Review). Oncology letters\| PubMed ID: 24137321	2013
Salvage treatment of relapsed or refractory germ-cell tumours. The Lancet. Oncology\| PubMed ID: 24176560	2013
Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease. BMC cancer\| PubMed ID: 24215543	2013
DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. Journal of experimental & clinical cancer research : CR\| PubMed ID: 24252461	2013
Retrospective analysis on the management of metastatic gastric cancer patients. A mono-institutional experience. What happens in clinical practice? Tumori\| PubMed ID: 24362861	2013
Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer. Expert opinion on pharmacotherapy\| PubMed ID: 24369047	2014
Standard vs adapted sunitinib regimen in elderly patients with metastatic renal cell cancer: results from a large retrospective analysis. Clinical genitourinary cancer\| PubMed ID: 24369790	2014
Benefit from anthracyclines in relation to biological profiles in early breast cancer. Breast cancer research and treatment\| PubMed ID: 24381054	2014
EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? PloS one\| PubMed ID: 24454858	2014
Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association\| PubMed ID: 24477419	2015
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer. Journal of geriatric oncology\| PubMed ID: 24495699	2014
Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers. Tumori\| PubMed ID: 24503807	2013
Targeting bone metastatic cancer: Role of the mTOR pathway. Biochimica et biophysica acta\| PubMed ID: 24508774	2014
177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study. European journal of nuclear medicine and molecular imaging\| PubMed ID: 24615468	2014
The emerging role of anti-angiogenic therapy in ovarian cancer (review). International journal of oncology\| PubMed ID: 24626312	2014
MicroRNAs and dendritic cell-based vaccination in melanoma patients. Melanoma research\| PubMed ID: 24638153	2014
KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC). PloS one\| PubMed ID: 24642661	2014
Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation. Molecular and clinical oncology\| PubMed ID: 24649213	2013
Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone. Endocrine-related cancer\| PubMed ID: 24741024	2014
Erratum to: Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association\| PubMed ID: 24760337	2015
Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies. Critical reviews in oncology/hematology\| PubMed ID: 24952997	2014
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. Bone\| PubMed ID: 24956020	2014
The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. The Journal of biological chemistry\| PubMed ID: 24966325	2014
First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer. BMC cancer\| PubMed ID: 24986639	2014
Taxanes as a risk factor for acute adverse reactions to iodinated contrast media in cancer patients. The oncologist\| PubMed ID: 25063226	2014
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy. Tumori\| PubMed ID: 25076256	2014
Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissue. International journal of molecular sciences\| PubMed ID: 25079441	2014
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. Journal of experimental & clinical cancer research : CR\| PubMed ID: 25091577	2014
Improved stool DNA integrity method for early colorectal cancer diagnosis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 25128402	2014
ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling. Nature cell biology\| PubMed ID: 25241036	2014
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide. The Prostate\| PubMed ID: 25262981	2014
Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report. Future oncology (London, England)\| PubMed ID: 25303054	2014
Clinical and genetic factors related to cancer-induced bone pain and bone pain relief. The oncologist\| PubMed ID: 25342315	2014
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients? BMC cancer\| PubMed ID: 25361734	2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature. OncoTargets and therapy\| PubMed ID: 25364262	2014
Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 25461293	2015
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone. Oncotarget\| PubMed ID: 25504434	2014
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report. Future oncology (London, England)\| PubMed ID: 25525851	2014
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection? International journal of molecular sciences\| PubMed ID: 25561229	2014
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women wi... The oncologist\| PubMed ID: 25637379	2015
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology letters\| PubMed ID: 25663927	2015
(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide. European journal of nuclear medicine and molecular imaging\| PubMed ID: 25808631	2015
Uncovering the genomic heterogeneity of multifocal breast cancer. The Journal of pathology\| PubMed ID: 25850943	2015
Erratum to: (18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide. European journal of nuclear medicine and molecular imaging\| PubMed ID: 25900277	2015
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. Journal of the National Cancer Institute\| PubMed ID: 25972604	2015
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer. Breast cancer research and treatment\| PubMed ID: 26012644	2015
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast. The International journal of biological markers\| PubMed ID: 26165687	2015
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia. Journal of translational medicine\| PubMed ID: 26174551	2015
Circulating tumor cells in early breast cancer: A connection with vascular invasion. Cancer letters\| PubMed ID: 26184997	2015
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 26206258	2015
Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. PloS one\| PubMed ID: 26244985	2015
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial. Journal of translational medicine\| PubMed ID: 26259598	2015
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy. Expert opinion on drug metabolism & toxicology\| PubMed ID: 26307328	2015
Plasma AR and abiraterone-resistant prostate cancer. Science translational medicine\| PubMed ID: 26537258	2015
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. OncoTargets and therapy\| PubMed ID: 26664145	2015
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report. BMC cancer\| PubMed ID: 26695071	2015
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy. Clinical lung cancer\| PubMed ID: 26712101	2016
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial. Oncotarget\| PubMed ID: 26848624	2016
The Mwanza Cancer Project. The Lancet. Oncology\| PubMed ID: 26868339	2016
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study. Oncology letters\| PubMed ID: 26870292	2016
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report. BMC cancer\| PubMed ID: 26887807	2016
Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma. Journal of neuro-oncology\| PubMed ID: 27029617	2016
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study. Oncotarget\| PubMed ID: 27058899	2016
The Comprehensive Cancer Care Network of Romagna: the opportunities generated by the OECI accreditation program. Tumori\| PubMed ID: 27096275	2015
Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions. Oncotarget\| PubMed ID: 27119511	2016
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. Oncotarget\| PubMed ID: 27120807	2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer. Oncotarget\| PubMed ID: 27191887	2016
Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors. Breast cancer research and treatment\| PubMed ID: 27393619	2016
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy. Breast cancer research and treatment\| PubMed ID: 27460638	2016
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 27472648	2016
Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing. The International journal of biological markers\| PubMed ID: 27516001	2016
Androgen receptor signaling pathways as a target for breast cancer treatment. Endocrine-related cancer\| PubMed ID: 27528625	2016
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model. International journal of molecular sciences\| PubMed ID: 27556456	2016
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 27568305	2017
[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines. International journal of oncology\| PubMed ID: 27573164	2016
RANKL: A promising circulating marker for bone metastasis response. Oncology letters\| PubMed ID: 27698885	2016
Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 27780855	2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. OncoTargets and therapy\| PubMed ID: 27785071	2016
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts. International journal of molecular sciences\| PubMed ID: 27809291	2016
Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Biology open\| PubMed ID: 27895047	2017
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 27903673	2017
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer. Oncotarget\| PubMed ID: 27911856	2017
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma. Molecules (Basel, Switzerland)\| PubMed ID: 27918490	2016
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of (18)FDG-PET/CT. Clinical lung cancer\| PubMed ID: 27956089	2017
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway. Oncotarget\| PubMed ID: 28061456	2017
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Ra... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 28113032	2017
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer. Oncotarget\| PubMed ID: 28186965	2017
CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Biology open\| PubMed ID: 28202474	2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas. OncoTargets and therapy\| PubMed ID: 28260930	2017
Sorafenib for the treatment of breast cancer. Expert opinion on pharmacotherapy\| PubMed ID: 28335647	2017
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer. Cancer chemotherapy and pharmacology\| PubMed ID: 28341957	2017
Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. Oncotarget\| PubMed ID: 28423363	2017
Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania. International journal of public health\| PubMed ID: 28424832	2017
Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab. Scientific reports\| PubMed ID: 28465540	2017
A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer. The oncologist\| PubMed ID: 28546463	2017
The challenge of sustainability in healthcare systems: Frequency and cost of inappropriate patterns of breast cancer care (the E.Pic.A study). Breast (Edinburgh, Scotland)\| PubMed ID: 28558338	2017
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. International journal of molecular sciences\| PubMed ID: 28598398	2017
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition. International journal of molecular sciences\| PubMed ID: 28758931	2017
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial. Scientific reports\| PubMed ID: 28874797	2017
Management and potentialities of primary cancer cultures in preclinical and translational studies. Journal of translational medicine\| PubMed ID: 29116016	2017
Primary leiomyosarcoma of the bone: a case report and a review of the literature. Medicine\| PubMed ID: 29137065	2017
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of ... Medicine\| PubMed ID: 29145267	2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nature communications\| PubMed ID: 29180617	2017
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents. International journal of molecular sciences\| PubMed ID: 29292724	2017
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nature communications\| PubMed ID: 29311577	2018
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. International journal of molecular sciences\| PubMed ID: 29361687	2018
Myxofibrosarcoma primary cultures: molecular and pharmacological profile. Therapeutic advances in medical oncology\| PubMed ID: 29449896	2017